(RDY) Dr. Reddy’s - Performance -6.1% in 12m
RDY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
18.51%
#52 in Peer-Group
Rel. Strength
34.48%
#5048 in Stock-Universe
Total Return 12m
-6.13%
#94 in Peer-Group
Total Return 5y
43.29%
#33 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 18.4 |
| P/E Forward | 17.9 |
| High / Low | USD |
|---|---|
| 52 Week High | 16.84 USD |
| 52 Week Low | 12.36 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 29.71 |
| Buy/Sell Signal +-5 | 1.44 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RDY (-6.1%) vs XLV (-10.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
1.74% | 120% | 333% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
-3.76% | -15.3% | 383% | 64.5 | 36.4 | 1.21 | 58.2% | 18.9% |
| NVS NYSE Novartis |
-1.62% | 6.12% | 68.4% | 18.6 | 14.5 | 1.42 | 8.70% | 9.2% |
| NOVN SW Novartis |
-2.33% | -2.4% | 45.4% | 18.8 | 14.5 | 1.42 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-8.18% | -4.42% | 37.9% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| IPN PA Ipsen |
3.7% | -2.93% | 42.8% | 25.8 | 10.4 | 0.74 | -6.40% | -6.33% |
| UCB BR UCB |
10% | 23.8% | 61.3% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
| AZN NASDAQ AstraZeneca |
-2.41% | -11.4% | 32.4% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
Performance Comparison: RDY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RDY
| Total Return (including Dividends) | RDY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -3.67% | -0.09% | 5.42% |
| 3 Months | 7.46% | -1.58% | 19.66% |
| 12 Months | -6.13% | -10.34% | 14.17% |
| 5 Years | 43.29% | 35.68% | 107.98% |
| Trend Stabilty (consistency of price movement) | RDY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -87.4% | 41.2% | 91.9% |
| 3 Months | 73.4% | -5% | 97.6% |
| 12 Months | -60.8% | -80.6% | 47.9% |
| 5 Years | 55.1% | 87.4% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th22.00 | -3.59% | -8.62% |
| 3 Month | %th40.50 | 9.18% | -10.19% |
| 12 Month | %th53.50 | 4.70% | -17.78% |
| 5 Years | %th82.50 | 5.61% | -31.10% |
FAQs
Does Dr. Reddy’s (RDY) outperform the market?
Yes,
over the last 12 months RDY made -6.13%, while its related Sector, the Health Care Sector SPDR (XLV) made -10.34%.
Over the last 3 months RDY made 7.46%, while XLV made -1.58%.
Performance Comparison RDY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RDY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.2% | -9.1% | -7.1% | -20% |
| US NASDAQ 100 | QQQ | -1% | -10% | -9.4% | -23% |
| German DAX 40 | DAX | 0.5% | -7.7% | -17.5% | -38% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.7% | -9.8% | -10.9% | -25% |
| Hongkong Hang Seng | HSI | -1.5% | -8.2% | -27.6% | -41% |
| India NIFTY 50 | INDA | 0.6% | -5.9% | -8.9% | -3% |
| Brasil Bovespa | EWZ | 0.3% | -2.2% | -21.2% | -8% |
RDY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.2% | -7.1% | -11.5% | -32% |
| Consumer Discretionary | XLY | 0.7% | -8.6% | 2.1% | -22% |
| Consumer Staples | XLP | 0.1% | -5.1% | -7.7% | -12% |
| Energy | XLE | 2.5% | -2.2% | 4.9% | -2% |
| Financial | XLF | 0.5% | -8.6% | -6.7% | -28% |
| Health Care | XLV | 2.8% | -3.6% | 3.1% | 4% |
| Industrial | XLI | -0.6% | -10.5% | -12.3% | -28% |
| Materials | XLB | 2.6% | -7.4% | -4.3% | -6% |
| Real Estate | XLRE | -0.1% | -4.5% | -4.5% | -12% |
| Technology | XLK | -1.5% | -12% | -13.3% | -23% |
| Utilities | XLU | 0.4% | -6.9% | -7.4% | -27% |
| Aerospace & Defense | XAR | -6.2% | -16.5% | -30.8% | -59% |
| Biotech | XBI | 0.4% | -11% | -1.6% | 6% |
| Homebuilder | XHB | 3.6% | -13.8% | 5.6% | 2% |
| Retail | XRT | 1.9% | -8.2% | -3.3% | -9% |
RDY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.9% | 3.79% | 6.30% | -1% |
| Natural Gas | UNG | -6.3% | 7% | 13% | -20% |
| Gold | GLD | -0.3% | -2.3% | -24.8% | -42% |
| Silver | SLV | -2.5% | -6.4% | -26.9% | -31% |
| Copper | CPER | 2% | -17.7% | -26.7% | -31% |
RDY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.3% | -2.4% | -1.1% | -0% |
| iShares High Yield Corp. Bond | HYG | 0.1% | -5% | -5.2% | -15% |